EI
PBYI icon

Ethic Inc’s Puma Biotechnology PBYI Stock Holding History

Ethic Inc’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.3K Sell
10,270
-260
-2% -$1.9K ﹤0.01% 1335
2026
Q1 		$67.3K Sell
10,530
-18
-0.2% -$116 ﹤0.01% 1210
2025
Q4 		$62.8K Buy
10,548
+195
+2% +$1.04K ﹤0.01% 1192
2025
Q3 		$55K Sell
10,353
-4,815
-32% -$20.4K ﹤0.01% 1175
2025
Q2 		$50.5K Buy
+15,168
New +$48.4K ﹤0.01% 1192

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ethic Inc's PBYI Position: Q2 2026 in Review

Ethic Inc reduced its Puma Biotechnology (PBYI) stake by 2.5% in Q2 2026, selling an estimated $1.9K and leaving 10,270 shares worth $83.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Ethic Inc first reported a position in PBYI in Q2 2025 and has held it in 5 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Ethic Inc held 10,270 shares of Puma Biotechnology worth $83.3K as of Q2 2026.
  • Ethic Inc sold 260 Puma Biotechnology shares in Q2 2026, an estimated $1.9K.
  • Puma Biotechnology made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1335 holding.
  • Ethic Inc first reported a position in Puma Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.